Rovelizumab Antibody
Rovelizumab is a humanized monoclonal antibody targeting the CD11/CD18 leukointegrin complex. It is a research tool for studying inflammatory conditions, with applications in experimental models of multiple sclerosis, stroke, myocardial infarction, and hemorrhagic shock.
Product Specifications
Target
Complement System, Integrin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Concentration
5.69 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog